Φορτώνει......
Opportunities and challenges for TCR mimic antibodies in cancer therapy
INTRODUCTION: Monoclonal antibodies (mAbs) are potent cancer therapeutic agents, but exclusively recognize cell-surface targets whereas most cancer-associated proteins are found intracellularly. Hence, potential cancer therapy targets such as overexpressed self-proteins, activated oncogenes, mutated...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Expert Opin Biol Ther |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
2016
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4936943/ https://ncbi.nlm.nih.gov/pubmed/27094818 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14712598.2016.1176138 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|